StockTipsArenaBeta

BUY Akums Drugs and Pharmaceuticals — Aastha Jain, Hem Securities

BUYAkums Drugs and Pharmaceuticals
Akums Drugs and Pharmaceuticals share price target & all analyst calls

byAastha Jain, Hem SecuritiesHorizon: 1–3 months11 Jun 2026via Zee Business (Live)

Entry₹598Stated
Target₹650
Total upside +8.70% (call closed)
Stop loss₹550-8.03% risk
Exit₹6507 Jul 2026, 12:00 am
Target hit+8.70%0.00%upside left
Follow Aastha Jain for new calls(55% target hit, 20 closed calls)Get alertsWatch AKUMS for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:05 am IST
3 supporting2 neutral0 opposing
Supports the BUY call (3)

Akums FY26 revenue rises 5.9% to ₹43,590.17 Mn

NewsGoogle News·20 Jun · 2w ago

(opens in new tab)

1 advisor has an active long-term BUY call on this stock

Advisor consensus · adjacent horizon·17 Feb · 5mo ago

Neutral / worth noting (2)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Akums Drugs and Pharmaceuticals

All analyst calls on Akums Drugs and Pharmaceuticals

More from Aastha Jain, Hem Securities

Every call and its outcome